Cargando…

Human Umbilical Cord Mesenchymal Stem Cells Inhibit the Function of Allogeneic Activated Vγ9Vδ2 T Lymphocytes In Vitro

Background. Human umbilical cord mesenchymal stem cells (UC-MSCs) can regulate the function of immune cells. However, whether and how UC-MSCs can modulate the function of Vγ9Vδ2 T cells has not been fully understood. Methods. The PBMCs or Vγ9Vδ2 T cells were activated and expanded with pamidronate (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Xiaohuan, Feng, Ting, Gong, Tianxiang, Shen, Chongyang, Zhu, Tingting, Wu, Qihong, Li, Qiang, Li, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423519/ https://www.ncbi.nlm.nih.gov/pubmed/25984529 http://dx.doi.org/10.1155/2015/317801

Ejemplares similares

Role of Vγ9vδ2 T lymphocytes in infectious diseases
por: Gay, Laetitia, et al.
Publicado: (2022)

Conditioned medium from umbilical cord mesenchymal stem cells induces migration and angiogenesis
por: SHEN, CHONGYANG, et al.
Publicado: (2015)

Phenotype and functional changes of Vγ9/Vδ2 T lymphocytes in Behçet's disease and the effect of infliximab on Vγ9/Vδ2 T cell expansion, activation and cytotoxicity
por: Accardo-Palumbo, Antonina, et al.
Publicado: (2010)

Human Vγ9Vδ2 T Lymphocytes in the Immune Response to P. falciparum Infection
por: Howard, Jennifer, et al.
Publicado: (2018)

Combined chemotherapy and allogeneic human Vγ9Vδ2 T lymphocyte-immunotherapies efficiently control the development of human epithelial ovarian cancer cells in vivo
por: Joalland, Noémie, et al.
Publicado: (2019)

Allogenic Vγ9Vδ2 T cell as new potential immunotherapy drug for solid tumor: a case study for cholangiocarcinoma
por: Alnaggar, Mohammed, et al.
Publicado: (2019)

Skewed Differentiation of Circulating Vγ9Vδ2 T Lymphocytes in Melanoma and Impact on Clinical Outcome
por: Toia, Francesca, et al.
Publicado: (2016)

Hepatocellular carcinoma cell sensitivity to Vγ9Vδ2 T lymphocyte-mediated killing is increased by zoledronate
por: SUGAI, SHIORI, et al.
Publicado: (2016)

CAR-Modified Vγ9Vδ2 T Cells Propagated Using a Novel Bisphosphonate Prodrug for Allogeneic Adoptive Immunotherapy
por: Wang, Yizheng, et al.
Publicado: (2023)

Sensing of Pyrophosphate Metabolites by Vγ9Vδ2 T Cells
por: Gu, Siyi, et al.
Publicado: (2015)

Functional Inactivation in the Whole Population of Human Vγ9/Vδ2 T Lymphocytes Induced By a Nonpeptidic Antagonist
por: Bürk, Martin R., et al.
Publicado: (1997)

Allogeneic Vγ9Vδ2 T-cell immunotherapy exhibits promising clinical safety and prolongs the survival of patients with late-stage lung or liver cancer
por: Xu, Yan, et al.
Publicado: (2020)

Irreversible electroporation plus allogenic Vγ9Vδ2 T cells enhances antitumor effect for locally advanced pancreatic cancer patients
por: Lin, Mao, et al.
Publicado: (2020)

The human Vδ2(+) T-cell compartment comprises distinct innate-like Vγ9(+) and adaptive Vγ9(-) subsets
por: Davey, Martin S., et al.
Publicado: (2018)

Improving the Efficiency of Vγ9Vδ2 T-Cell Immunotherapy in Cancer
por: Hoeres, Timm, et al.
Publicado: (2018)

Development and Selection of the Human Vγ9Vδ2(+) T-Cell Repertoire
por: Willcox, Carrie R., et al.
Publicado: (2018)

The PPARα pathway in Vγ9Vδ2 T cell anergy
por: Poupot, Mary, et al.
Publicado: (2014)

Releasing the restraints of Vγ9Vδ2 T-cells in cancer immunotherapy
por: Ridgley, Laura A., et al.
Publicado: (2023)

Intramuscular Transplantation of Allogeneic Mesenchymal Stromal Cells Derived from Equine Umbilical Cord
por: Dias, Marianne Camargos, et al.
Publicado: (2016)

Activation and selective IL-17 response of human Vγ9Vδ2 T lymphocytes by TLR-activated plasmacytoid dendritic cells
por: Presti, Elena Lo, et al.
Publicado: (2016)

Preferential Infiltration of Unique Vγ9Jγ2-Vδ2 T Cells Into Glioblastoma Multiforme
por: Lee, Mijeong, et al.
Publicado: (2019)

Role of Vγ9Vδ2+ γδ T cells in juvenile idiopathic arthritis
por: Gerstein, M, et al.
Publicado: (2008)

BTLA, a key regulator of Vγ9Vδ2 T-cell proliferation
por: Gertner-Dardenne, Julie, et al.
Publicado: (2013)

An Update on the Molecular Basis of Phosphoantigen Recognition by Vγ9Vδ2 T Cells
por: Herrmann, Thomas, et al.
Publicado: (2020)

Allogeneic Vγ9Vδ2 T-Cell Therapy Promotes Pulmonary Lesion Repair: An Open-Label, Single-Arm Pilot Study in Patients With Multidrug-Resistant Tuberculosis
por: Liang, Juan, et al.
Publicado: (2021)

Allogenic umbilical cord tissue for temporomandibular joint injuries
por: Aratikatla, Adarsh, et al.
Publicado: (2023)

Mistletoe-Extract Drugs Stimulate Anti-Cancer Vγ9Vδ2 T Cells
por: Ma, Ling, et al.
Publicado: (2020)

Functional Phenotypes of Human Vγ9Vδ2 T Cells in Lymphoid Stress Surveillance
por: Nussbaumer, Oliver, et al.
Publicado: (2020)

Effector Vγ9Vδ2 T cell response to congenital Toxoplasma gondii infection
por: Ma, Ling, et al.
Publicado: (2021)

Generation and application of TGFβ-educated human Vγ9Vδ2 T cells
por: Parente-Pereira, Ana C., et al.
Publicado: (2022)

Vγ9Vδ2 T-cell immunotherapy in blood cancers: ready for prime time?
por: Giannotta, Claudia, et al.
Publicado: (2023)

Enrichment of human Vγ9Vδ2 T lymphocytes by magnetic poly(divinylbenzene-co-glycidyl methacrylate) colloidal particles conjugated with specific antibody
por: Sawaisorn, Piamsiri, et al.
Publicado: (2018)

Vγ9γδ T Cell Induction by Human Umbilical Cord Blood Monocytes-Derived, Interferon-α-Stimulated Dendritic Cells
por: Anh, Bui Viet, et al.
Publicado: (2020)

Interferon-γ alters the microRNA profile of umbilical cord-derived mesenchymal stem cells
por: Chi, Ying, et al.
Publicado: (2016)

Wound Healing by Allogeneic Transplantation of Specific Subpopulation From Human Umbilical Cord Mesenchymal Stem Cells
por: Palma, María Belén, et al.
Publicado: (2021)

Cost Effectiveness of Allogeneic Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Patients with Knee Osteoarthritis
por: Suh, Kangho, et al.
Publicado: (2022)

IDO Inhibition Facilitates Antitumor Immunity of Vγ9Vδ2 T Cells in Triple-Negative Breast Cancer
por: Li, Peng, et al.
Publicado: (2021)

Umbilical cord blood: A promising source for allogeneic CAR-T cells
por: Liu, Dian-Dian, et al.
Publicado: (2022)

Specific tumor targeting and activation of Vγ9Vδ2 T cells by bi-specific nanobodies
por: Stam, Anita, et al.
Publicado: (2014)

Peripheral Vγ9Vδ2 T Cells Are a Novel Reservoir of Latent HIV Infection
por: Soriano-Sarabia, Natalia, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_8qqu3ao2srfuhjqprkivh3nmu8